PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2013Heart37 citations

The dose of running that best confers longevity

View Full Paper
JOJames H. O’KeefePSPeter SchnohrCLCarl J. Lavie

Key Result

Jogging was associated with a 44% lower risk of mortality compared with non-joggers, increasing age-adjusted survival by about 6 years, though high-intensity running diminished these gains.

Structured PICO

Does jogging improve longevity compared to non-jogging?

P
Population
12,036 individuals, comprising 1,878 joggers and 10,158 non-joggers, followed for up to 35 years to assess the impact of jogging on longevity.
E
Exposure
Jogging (various quantities, speeds, and frequencies)
C
Comparator
Non-joggers
O
Outcome
Mortalityhard clinical

Moderate jogging (1-2.5 hours/week, slow to moderate pace, 2-3 times/week) confers optimal longevity benefits, while excessive running diminishes these gains.

Main Result

Effect estimate: 44% lower risk

Abstract

The Authors' reply In the interim since our editorial was published,1 the Copenhagen City Heart Study focusing on longevity in joggers, has been published in a prestigious peer-reviewed journal.2 This large prospective longitudinal observational study followed 1878 joggers and 10 158 non-joggers for up to 35 years. They found that joggers, as compared with the non-joggers, had a remarkable 44% lower risk of mortality during follow-up for both men and women. The age-adjusted increase in survival was about 6 years in both genders. However, U-shaped curves were apparent for mortality with respect to quantity of jogging (figure 1), estimated running speed (figure 2), and frequency of jogging (figure 3). These curves suggest that the benefits of jogging are most robust for those who jog between 1 and 2.5 h per week, at a slow to moderate pace, at a frequency of about 2 or 3 times per week. In those joggers who were doing a higher volume, higher-intensity running, the long-term mortality rates were not significantly different from non-joggers. In other words, overdoing the running substantially diminishes the remarkable gains in longevity conferred by moderate jogging. Figure 1 Quantity of jogging and mortality. Green bars: significantly different than non-joggers (referent). Figure 2 Jogging pace (running speed as estimated by the jogger) and mortality. Green bars: significantly different than non-joggers (referent). Figure 3 Frequency …

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

O’Keefe et al. (2013) reported a letter. Jogging vs. Non-joggers was evaluated on Mortality (44% lower risk). Jogging was associated with a 44% lower risk of mortality compared with non-joggers, increasing age-adjusted survival by about 6 years, though high-intensity running diminished these gains.

synapsesocial.com/papers/6a5be7a819e8c79e69b986a8https://doi.org/10.1136/heartjnl-2013-303683
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dose of Jogging and Long-Term Mortality2015 · 421 citations
  2. 2Longevity in Male and Female Joggers: The Copenhagen City Heart Study2013 · 115 citations
  3. 3Mortality in joggers: population based study of 4658 men2000 · 36 citations
  4. 4Optimal Running Dose and Cardiovascular Risk2018 · 15 citations
  5. 5Persistent physical activity translating to persistent reduction in mortality2017 · 7 citations